DIN 02461463 — ODEFSEY 25 MG; 200 MG; 25 MG
ODEFSEY is a tablet of Emtricitabine / Rilpivirine / Tenofovir Alafenamide marketed by GILEAD SCIENCES CANADA INC. The full Emtricitabine / Rilpivirine / Tenofovir Alafenamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02461463
- Brand name
- ODEFSEY
- Active ingredient
- Emtricitabine / Rilpivirine / Tenofovir Alafenamide
- Strength
- 25 MG; 200 MG; 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Fixed-dose antiretroviral combination (NRTI + NNRTI + nucleotide reverse transcriptase inhibitor prodrug)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.